Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

[Solitary fibrous tumor of the retroperitoneum with urinary symptoms revealing a Doege-Potter's syndrome].

Gomez FD, Robin L, Jakubowicz D, Sillou S, Lab JP, Balian C.

Prog Urol. 2019 Mar;29(3):136-137. doi: 10.1016/j.purol.2019.02.004. Epub 2019 Feb 25. French. No abstract available.

PMID:
30819633
2.

Bariatric surgery in patients with type 1 diabetes: special considerations are warranted.

Landau Z, Kowen-Sandbank G, Jakubowicz D, Raziel A, Sakran N, Zaslavsky-Paltiel I, Lerner-Geva L, Pinhas-Hamiel O.

Ther Adv Endocrinol Metab. 2019 Jan 30;10:2042018818822207. doi: 10.1177/2042018818822207. eCollection 2019.

3.

Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study.

Sharif K, Ghadir S, Jakubowicz D, Amital H, Bragazzi NL, Watad A, Wainstein J, Bar-Dayan Y.

Cardiovasc Diabetol. 2019 Jan 11;18(1):4. doi: 10.1186/s12933-019-0810-8.

4.

Hypoglycemia- simplifying the ways to predict an old problem in the general ward.

Bar-Dayan Y, Wainstein J, Schorr L, Derazne E, Schorr Y, Jakubowicz D, Wohl Y.

Eur J Intern Med. 2019 Feb;60:13-17. doi: 10.1016/j.ejim.2018.10.007. Epub 2018 Nov 28.

PMID:
30503083
5.

Early surgical management for giant omphalocele: Results and prognostic factors.

Roux N, Jakubowicz D, Salomon L, Grangé G, Giuseppi A, Rousseau V, Khen-Dunlop N, Beaudoin S.

J Pediatr Surg. 2018 Oct;53(10):1908-1913. doi: 10.1016/j.jpedsurg.2018.04.036. Epub 2018 May 24.

PMID:
29803304
6.

High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes.

Jakubowicz D, Wainstein J, Landau Z, Ahren B, Barnea M, Bar-Dayan Y, Froy O.

J Nutr Biochem. 2017 Nov;49:1-7. doi: 10.1016/j.jnutbio.2017.07.005. Epub 2017 Jul 21.

PMID:
28863364
7.

Lifestyle intervention program benefits children with overweigh compared to children with obesity.

Landau Z, Abiri S, Lebenthal Y, Jakubowicz D, Mor N, Lerner-Geva L, Boaz M, Wainstein J, Bar-Dayan Y.

Obes Res Clin Pract. 2018 Jan - Feb;12(1):85-92. doi: 10.1016/j.orcp.2017.07.003. Epub 2017 Aug 31.

PMID:
28838814
8.

Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial.

Jakubowicz D, Wainstein J, Landau Z, Raz I, Ahren B, Chapnik N, Ganz T, Menaged M, Barnea M, Bar-Dayan Y, Froy O.

Diabetes Care. 2017 Nov;40(11):1573-1579. doi: 10.2337/dc16-2753. Epub 2017 Aug 22.

PMID:
28830875
9.

Random blood glucose screening at a public health station encouraged high risk subjects to make lifestyle changes.

Elman K, Wainstein J, Boaz M, Jakubowicz D, Bar-Dayan Y.

Int J Clin Pract. 2017 Aug;71(8). doi: 10.1111/ijcp.12984. Epub 2017 Jul 30.

PMID:
28758307
10.

Prevalence of undiagnosed hyperglycaemia in patients presenting to the Department of Emergency Medicine with no known history of diabetes.

Bar-Dayan Y, Zilberman I, Boaz M, Landau Z, Glandt M, Jakubowicz D, Wainstein J.

Int J Clin Pract. 2016 Sep;70(9):771-4. doi: 10.1111/ijcp.12867. Epub 2016 Aug 16.

PMID:
27531637
11.
12.

Using a public health station for screening of undiagnosed dysglycemia and hypertension.

Bar-Dayan Y, Boaz M, Landau Z, Zeev F, Jakubowicz D, Wainstein J.

Prim Care Diabetes. 2016 Oct;10(5):324-8. doi: 10.1016/j.pcd.2016.02.001. Epub 2016 Mar 8.

PMID:
26968251
13.

Purslane Extract and Glucose Homeostasis in Adults with Type 2 Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety.

Wainstein J, Landau Z, Bar Dayan Y, Jakubowicz D, Grothe T, Perrinjaquet-Moccetti T, Boaz M.

J Med Food. 2016 Feb;19(2):133-40. doi: 10.1089/jmf.2015.0090.

PMID:
26854844
14.

Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.

Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O.

Diabetes Care. 2015 Oct;38(10):1820-6. doi: 10.2337/dc15-0761. Epub 2015 Jul 28.

PMID:
26220945
15.

Hyperglycaemia in patients with no history of diabetes presenting to Internal Medicine Departments.

Bar-Dayan Y, Beer I, Boaz M, Landau Z, Jakubowicz D, Wainstein J.

Int J Clin Pract. 2015 Nov;69(11):1289-95. doi: 10.1111/ijcp.12690. Epub 2015 Jul 14.

PMID:
26178790
16.

High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial.

Jakubowicz D, Wainstein J, Ahrén B, Bar-Dayan Y, Landau Z, Rabinovitz HR, Froy O.

Diabetologia. 2015 May;58(5):912-9. doi: 10.1007/s00125-015-3524-9. Epub 2015 Mar 1.

PMID:
25724569
17.

Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial.

Jakubowicz D, Froy O, Ahrén B, Boaz M, Landau Z, Bar-Dayan Y, Ganz T, Barnea M, Wainstein J.

Diabetologia. 2014 Sep;57(9):1807-11. doi: 10.1007/s00125-014-3305-x. Epub 2014 Jul 10.

PMID:
25005331
18.

Big breakfast rich in protein and fat improves glycemic control in type 2 diabetics.

Rabinovitz HR, Boaz M, Ganz T, Jakubowicz D, Matas Z, Madar Z, Wainstein J.

Obesity (Silver Spring). 2014 May;22(5):E46-54. doi: 10.1002/oby.20654. Epub 2013 Dec 6.

19.

The use of a CoolSense device to lower pain sensation during finger pricking while measuring blood glucose in diabetes patients--a randomized placebo.

Wainstein J, Chimin G, Landau Z, Boaz M, Jakubowicz D, Goddard G, Bar-Dayan Y.

Diabetes Technol Ther. 2013 Aug;15(8):688-94. doi: 10.1089/dia.2012.0278. Epub 2013 Jul 17.

PMID:
23863047
20.

Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.

Jakubowicz D, Barnea M, Wainstein J, Froy O.

Clin Sci (Lond). 2013 Nov;125(9):423-32. doi: 10.1042/CS20130071.

PMID:
23688334
21.

High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women.

Jakubowicz D, Barnea M, Wainstein J, Froy O.

Obesity (Silver Spring). 2013 Dec;21(12):2504-12. doi: 10.1002/oby.20460. Epub 2013 Jul 2.

22.

Hepatic endometrioma: a case report and review of the literature: report of a case.

Rivkine E, Jakubowicz D, Marciano L, Polliand C, Poncelet C, Ziol M, Barrat C.

Surg Today. 2013 Oct;43(10):1188-93. doi: 10.1007/s00595-012-0360-0. Epub 2012 Oct 19. Review.

PMID:
23080414
23.

Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes.

Jakubowicz D, Froy O.

J Nutr Biochem. 2013 Jan;24(1):1-5. doi: 10.1016/j.jnutbio.2012.07.008. Epub 2012 Sep 17. Review.

PMID:
22995389
24.

The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel.

Jakubowicz D, Wainstein J, Homburg R.

Isr Med Assoc J. 2012 Jul;14(7):442-7. No abstract available.

25.

Meal timing and composition influence ghrelin levels, appetite scores and weight loss maintenance in overweight and obese adults.

Jakubowicz D, Froy O, Wainstein J, Boaz M.

Steroids. 2012 Mar 10;77(4):323-31. doi: 10.1016/j.steroids.2011.12.006. Epub 2011 Dec 9. Erratum in: Steroids. 2012 Jul;77(8-9):887-9.

PMID:
22178258
26.

Use of becaplermin in the closure of pharyngocutaneous fistulas.

Jakubowicz DM, Smith RV.

Head Neck. 2005 May;27(5):433-8.

PMID:
15776464
27.
28.

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.

Fertil Steril. 2004 Oct;82(4):893-902.

PMID:
15482765
29.

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.

Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE.

Endocr Pract. 2002 Nov-Dec;8(6):417-23.

PMID:
15251831
30.

Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy.

Jakubowicz DJ, Essah PA, Seppälä M, Jakubowicz S, Baillargeon JP, Koistinen R, Nestler JE.

J Clin Endocrinol Metab. 2004 Feb;89(2):833-9.

PMID:
14764802
31.

Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.

Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Apridonidze T, He N, Nestler JE.

J Clin Endocrinol Metab. 2004 Jan;89(1):242-9.

PMID:
14715857
32.

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.

Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Nestler JE.

J Clin Endocrinol Metab. 2003 May;88(5):1927-32. Review. No abstract available.

PMID:
12727935
33.

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome.

Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE.

J Clin Endocrinol Metab. 2002 Feb;87(2):524-9.

PMID:
11836280
34.

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.

Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ.

Fertil Steril. 2002 Feb;77(2):209-15. Review.

PMID:
11821072
35.

Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.

Jakubowicz DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R, Nestler JE.

J Clin Endocrinol Metab. 2001 Mar;86(3):1126-33.

PMID:
11238496
36.

Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.

Nestler JE, Jakubowicz DJ, Iuorno MJ.

J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1295-8. Review.

PMID:
11117673
37.

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.

Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G.

N Engl J Med. 1999 Apr 29;340(17):1314-20.

38.

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R.

N Engl J Med. 1998 Jun 25;338(26):1876-80.

39.
40.
43.

Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men.

Beer NA, Jakubowicz DJ, Matt DW, Beer RM, Nestler JE.

Am J Med Sci. 1996 May;311(5):205-10.

PMID:
8615394
44.

Effect of dehydroepiandrosterone on cyclic-guanosine monophosphate in men of advancing age.

Jakubowicz D, Beer N, Rengifo R.

Ann N Y Acad Sci. 1995 Dec 29;774:312-5. No abstract available.

PMID:
8597474
45.

Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women.

Jakubowicz DJ, Beer NA, Beer RM, Nestler JE.

J Clin Endocrinol Metab. 1995 Nov;80(11):3373-6.

PMID:
7593454
46.
47.

Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.

Beer NA, Jakubowicz DJ, Beer RM, Nestler JE.

J Clin Endocrinol Metab. 1994 Oct;79(4):1077-81.

PMID:
7962276
48.

Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men.

Nestler JE, Beer NA, Jakubowicz DJ, Beer RM.

J Clin Endocrinol Metab. 1994 Mar;78(3):549-54.

PMID:
8126125
50.

Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.

Beer NA, Jakubowicz DJ, Beer RM, Arocha IR, Nestler JE.

J Clin Endocrinol Metab. 1993 Jan;76(1):178-83.

PMID:
8421087

Supplemental Content

Loading ...
Support Center